Restrictive cardiomyopathy (RCM) is a rare and distinct form of cardiomyopathy characterized by normal ventricular chamber dimensions, normal myocardial wall thickness, and preserved systolic function. The abnormal myocardium, however, demonstrates impaired relaxation. To date, dominant variants causing RCM have been reported in a small number of sarcomeric or cytoskeletal genes, but the genetic causes in a majority of cases remain unexplained, especially in early childhood. Here, we describe two RCM families with childhood onset: one in a large family with a history of autosomal dominant RCM and the other a family with affected monozygotic, dichorionic/diamniotic twins. Exome sequencing found a pathogenic filamin C (FLNC) variant in each: p.Pro2298Leu, which segregates with disease in the large autosomal dominant RCM family, and p.Tyr2563Cys in both affected twins. In vitro expression of both mutant proteins yielded aggregates of FLNC containing actin in C2C12 myoblast cells. Recently, a number of variants in FLNC have been described that cause hypertrophic, dilated, and restrictive cardiomyopathies. Our data presented here provide further evidence for the role of FLNC in pediatric RCM, and suggest the need to include FLNC in genetic testing of cardiomyopathy patients including those with early ages of onset.
INTRODUCTION
Cardiomyopathy (CM), a disease of heart muscle causing systolic and/or diastolic dysfunction, is a common cause of cardiac failure in children (Wilkinson, Westphal, Ross, Dauphin, & Lipshultz, 2015) . Phenotypes include dilated (DCM), hypertrophic (HCM), restrictive (RCM), and arrhythmogenic forms (AVC), as well as left ventricular noncompaction (LVNC). RCM, the rarest of the cardiomyopathies, is defined as restrictive ventricular physiology in the presence of normal or reduced diastolic volumes, normal or reduced systolic volumes, and normal ventricular wall thickness (Vatta & Towbin, 2011) . RCM accounts for up to 5% of cardiomyopathies in children, with the majority having no specific cause identified. The prognosis in children with RCM is poornearly 50% of patients die or undergo transplant within 3 years of diagnosis (Russo, 2005; Webber et al., 2012) . Familial RCM is reported in 30% of all cases and both autosomal recessive and autosomal dominant inheritance have been described (Denfield & Webber, 2010) . In some families with autosomal dominant CM, both HCM and RCM have been identified, suggested shared genetic causes (Kaski, Biagini, Lorenzini, Rapezzi, & Elliott, 2012) . To date more than 100 genes have been implicated in various forms of CM (Tariq & Ware, 2014; Ware, 2015; Ware, 2017) . These genes are involved in sarcomeric cytoskeletal, desmosomal or mitochondrial organization, metabolic processes, and other additional cellular functions (Harvey & Leinwand, 2011) .
Despite progress in identifying various genetic causes for cardiomyopathies, little is known about the genetic etiology of RCM. To date, dominant pathogenic variants causing RCM have been reported in DES, ACTC1, TNNI3, TNNT2, TPM1, MYL3, MYL, MYPN, TTN, BAG3, FLNC, TTR, and MYH7 , but the majority of cases are considered idiopathic (Towbin, 2014) . However, recent studies of idiopathic RCM cohorts tested using panels of 100-200 CM-related genes show some RCM (Ackerman et al., 2011) , data are limited. Identification of further genetic causes for RCM will be the first step for understanding the disease mechanisms, which may eventually lead to gene-specific diagnosis and potential therapy.
Filamins are a group of large proteins important for structural integrity of cells that act by crosslinking actin filaments and anchoring membrane proteins to the cytoskeleton. Variants in FLNC have not only been reported in RCM patients but also in other cardiomyopathies and skeletal muscle diseases (Brodehl et al., 2016; Valdés-Mas et al., 2014; Vorgerd et al., 2005) . In this study, we investigated two families with early onset RCM, identified FLNC variants using an exome sequencing (ES) approach, and performed in vitro functional analyses. Using these approaches, we sought to expand the current spectrum of genetic variants associated with familial RCM. 
METHODS

Ascertainment of familial RCM and ethical considerations
Exome sequencing
For Family 1, exome sequencing (ES) was performed on a research basis. Genomic DNA (2 g) from proband IV-2 ( Figure 1a ) was used for enrichment of human exonic sequences with the NimbleGen SeqCap EZ Human Exome v2.0 Library (2.1 million DNA probes; Roche NimbleGen, Inc., Madison, WI). Sequencing was performed with 50 bp paired-end reads using Illumina (San Diego, CA) GAII (v2 Chemistry) to a mean depth of approximately 56×. All sequence reads were mapped to the reference human genome (UCSC hg 19) F I G U R E 2 Family 2 phenotypic and genetic evaluation. (a) Four-generation pedigree of Family 2 with RCM in twin sisters. DNA samples were available from individuals with a star sign. Proband IV-7 was analyzed by exome sequencing. All individuals with DNA available were sequenced for the FLNC variant which was found to be de novo in the twins. using the Illumina Pipeline software version 1.5 featuring a gapped aligner (ELAND v2). Variant identification was performed using GATK (McKenna et al., 2010) . Amino acid changes were identified by comparison to the UCSC RefSeq database track. A local CCHMC realignment tool was used to minimize the errors in SNP calling due to indels. Exome data were initially screened for more than 300 genes known for CM or related phenotypes. Our filtering strategy removed previously reported variants in databases such as dbSNP (Sherry et al., 2001 ) and NHLBI Exome Sequencing Project (ESP) (https://evs.gs.washington.edu/EVS/), in addition to non-coding vari-
ants. Remaining variants were tested for segregation with disease in the family, and further subject to pathogenicity prediction programs including: Polyphen-2, SIFT/PROVEAN, MutationTaster, and HOPE (Adzhubei et al., 2010; Choi, Sims, Murphy, Miller, & Chan, 2012; Schwarz, Cooper, Schuelke, & Seelow, 2014; Venselaar, Te Beek, Kuipers, Hekkelman, & Vriend, 2010) . 
Variant screening and validation
Primers (Supp. (Krieger & Vriend, 2014) was used to view both protein structures.
Cell culture, plasmid transfection, and immunocytochemistry
A human FLNC clone was purchased from Origene (Rockville, MD, catalog number RG212462) in a mammalian expression vector pCMV-AC-GFP. Mutagenesis was performed using primers designed (Supp. were cultured with 2 ml Dulbecco's modified Eagle medium (DMEM) containing 10% fetal bovine serum (Hyclone, Pittsburgh, PA) and 1%
penicillin-streptomyocyin (Gibco, Waltham, MA) in a 2 well (4.0 cm 2 )
Lab-Tek chamber slide (Nunc, Rochester, NY) to reach 60% confluence on the day prior to transfection. To transfect, 5 g of pCMV-AC-GFP FLNC wild-type or mutant plasmids were combined with 8 l of 2 M CaCl 2 . This mix was added dropwise to 62.5 l 2X HEPES buffered saline. After 30 min of precipitation, the combined solution was added to the culture media and incubated overnight. After incubation, the transfection media was replaced with 2 ml fresh media. For Neon electroporation, 100,000 C2C12 cells and 0.75 g of plasmid DNA were used in each transfection using electroporation conditions of 1,650 V, 10 ms pulse width, and pulse number 3. Cells were plated into two well chamber slides with 2 ml of the above described DMEM. 
Pathology
Explanted heart tissue was fixed in 10% neutral buffered formalin for 24 hr at room temperature before embedding in paraffin (FFPE), sectioning, and staining with hematoxylin and eosin (H&E) or trichrome.
Additionally, a portion of the ventricle was fixed in 3% glutaraldehyde in cacodylate buffer, and sectioned to one cubic millimeter for processing and imaging by transmission electron microscopy.
RESULTS
Phenotypic evaluation
Family 1 showed a typical autosomal dominant mode of inheritance 
Pathology
Explanted heart tissue from the proband in Family 1 was processed for both histology and transmission electron microscopy (EM). H&E staining revealed some myocyte hypertrophy, nuclear size changes, and occasional central nuclei (Figure 3a) , whereas trichrome staining at lower magnification showed some differences in fiber sizes and lacy 
Exome analysis
After variant filtering, we identified 3 candidate variants in the Figure S1 ). Additionally, these variants were predicted to be benign by pathogenicity prediction, were found in variant databases such as ExAC and dbSNP, and neither twin presented classical signs 
In silico pathogenicity prediction
Both the autosomal dominant p.Pro2298Leu and de novo p.Tyr2563Cys variants in FLNC were unanimously predicted to be pathogenic using bioinformatic programs Polyphen-2, SIFT/ PROVEAN, and Mutation Taster (Supp . Table S4 ). Further, the program HOPE (Venselaar et al., 2010) was used to discover and analyze potential changes to protein structure resulting from each variant (Supp . Table S4 ). Proline at position 2298 of FLNC, as well as its respective triplet codon (CCC) in the gene, are evolutionary conserved across species suggesting an important role of this residue in protein function (Figure 1d ). Prolines are known to be very rigid and therefore induce a special backbone conformation which might be required at this position. All filamins consist of an N-terminus actin-binding domain followed by 24 antiparallel -sheet repeats (called filamin or Ig-like domains), the 24 th of which is responsible for filamin homodimerization at the C terminus (Stossel et al., 2001 ). These 24 Ig filamin repeats of the FLNC protein primarily form a secondary structure of beta strands, as seen in a model of Ig domains 20-21 (Figure 4a ) (Sjekloća et al., 2007) . The side chain of proline will typically disrupt -strands due to its unique ring structure (Li, Goto, Williams, & Deber, 1996) , and indeed proline 2298 falls in a loop between two such strands ( Figure 4b ). The change to leucine at this position could disturb this special conformation and lead to protein aggregates. -rich proteins like FLNC are prone to aggregation, and a leucine substitution could have a higher propensity to form hydrogen bonds between other nearby -strands which could potentially disrupt protein folding and lead to aggregate formation (Hecht, 1994; Venselaar et al., 2010) .
Tyrosine at position 2563 is also evolutionarily conserved across species (Figure 2d ), and is located at the end of a -strand (Figure 4c,d ).
The mutant cysteine residue is less hydrophobic and smaller than the wild-type tyrosine, and due to its size is predicted to cause an empty space in the protein. The difference in hydrophobicity is also predicted to lead to a loss of hydrogen bonds at the core, which could disturb proper protein folding (Venselaar et al., 2010) . In addition to changes to hydrophobicity, the specific tyrosine to cysteine substitution may also be contributing to p.Tyr2563Cys protein aggregation (shown in results below). Substitution of tyrosine and cysteine at key resides of the human -synuclein protein has been shown to cause accelerated protein aggregation in vitro, likely due to the increased ability for cysteine residues to cross-link and form stable dimers, which could be more prone to polymerization and aggregation (Zhou & Freed, 2004) . 
In vitro analysis of FLNC mutants
DISCUSSION
In this study, we described two families with novel FLNC variants as disease causing for RCM: one in a large family with autosomal dominant inheritance and the other in a set of monozygotic, dichorionic/diamniotic twins with extra-cardiac features and a de novo variant.
According to the 2015 ACMG variant interpretation guidelines, both variants can be classified as pathogenic. Our evidence to support pathogenicity for p.Pro2298Leu includes: damaging in vitro functional study (PS3); variant found in a mutation hot-spot of CM variants (PM1-see FLNC is a Z-disk protein which binds to myozenin-1 and myotilin, and its expression is largely restricted to skeletal and cardiac muscles (Linnemann et al., 2010; van der Ven et al., 2006) . In addition,
FLNC interacts with components of dystrophin-dystroglycan complex at the sarcolemma, thus acting as a scaffolding protein (Thompson et al., 2000) . Altogether, Filamins interact with more than 90 cellular proteins with diverse functions including cell to cell and cell matrix connections, mechanoprotection, and various signaling networks (Feng & Walsh, 2004; Razinia, Mäkelä, Ylänne, & Calderwood, 2012) . Recent data by Leber et al. (2016) show evidence of FLNC as a key early protein involved in myofibril repair for both skeletal and cardiac muscle cells. Their work suggests FLNC may be more of a mobile signaling hub rather than a largely structural and static protein (Leber et al., 2016) .
The early onset of RCM in the presented families suggests the importance of FLNC expression and its role in heart function.
FLNC variants are a recently recognized cause of phenotypically distinct cardiomyopathies including HCM, DCM, and RCM (Begay et al., 2016; Brodehl et al., 2016; Valdés-Mas et al., 2014) .
FLNC-related cardiomyopathies present a challenge in extrapolating genotype-phenotype correlations based on variant position (Table 1) . in the latter half of the protein (Gómez et al., 2017) . Of interest, one likely pathogenic variant identified by Gómez et al. (2017) et al. (2017) , and variants published by Brodehl et al. (2016) (Begay et al., 2016; Begay et al., 2018; Golbus et al., 2014) , while three are nonsense variants resulting in an early protein truncation (Begay et al., 2018; Reinstein et al., 2016) . Genetic screening of large DCM patient cohorts revealed an association with truncating FLNC variants (stop codons, frameshifts, and splice site variants), strongly suggesting an overlap between mutational mechanisms and patient phenotype (Janin et al., 2017; OrtizGenga et al., 2016) . Until recently, skeletal myopathy and CM-causing FLNC variants have been reported to cause isolated phenotypes in their respective tissues. Interestingly, however, a new publication has described disease-causing FLNC variants leading to both early-onset RCM and the skeletal muscle phenotypes congenital myopathy and clasped thumbs (Kiselev et al., 2018) . The patients described here showed no evidence of myopathy on repeated exams although the twins did exhibit hypotonia. In light of the report by Kiselev et al. (2018) , it is possible the p.Tyr2563Cys variant could be contributing to the twins' observed skeletal muscle phenotypes (hyoptonia and clasped thumbs), although this variant is not near the two variants Kiselev et al. (2018) found (p.Ala1183Leu and p.Ala1186Val). However, we do not believe the twins' other syndromic-like phenotypes, such as developmental delay and dysmorphic facial features, can likely be explained by a FLNC variant alone, and those hint at the possibility of a second underlying disorder. Additional functional studies will be necessary to determine the FLNC variant-specific effects resulting in isolated skeletal or heart muscle disease, or those which affect both tissues. In addition, mechanisms to explain the divergent cardiac phenotypes resulting from distinct FLNC variants remain to be elucidated.
Functional and structural analyses suggest that FLNC-mutants recruit FLNC-associated proteins to form aggregates, leading to destabilization of muscle tissue (Lowe et al., 2007; Luan, Hong, Zhang, Wang, & Yuan, 2010) . Abnormal accumulations of FLNC deposits in patients' muscle tissues have been reported in a number of neuromuscular diseases (Bönnemann et al., 2003; Sewry et al., 2002; Thompson et al., 2000) . In vitro analyses for mutant FLNC p.Pro2298Leu revealed formation of perinuclear intracellular aggregates, while p.Tyr2563Cys expressing cells also formed point aggregates containing FLNC and F-actin, confirming the likely pathogenicity of these variants. Of note, similar experiments for HCM, DCM, and RCM FLNC mutants also resulted in aggregations of mutant protein, many of which shared a similar pattern of aggregate expression around the nucleus (Brodehl et al., 2016 , Reinstein et al., 2016 Valdés-Mas et al., 2014) . The exact mechanism for this aggregate-based pathogenicity is unknown, but this could be an error in ubiquitination and lysosomaldependent degradation of mutant FLNC as well as of other members of filamins.
Changes in filamin structure initiate the binding of the cochaperone BAG3 as well as the ubiquitin ligase CHIP. CHIP ubiquitinates BAG3 and filamin leading to autophagy by the p62 pathway (Arndt et al., 2010) . Recent data suggest aggregates produced by the filamin C p.Trp2710X MFM variant in zebrafish were unable to be cleared properly by BAG3 and the chaperone assisted selective autophagy pathway (Ruparelia, Oorschot, Ramm, & BrysonRichardson, 2016) . Additionally, they noted the presence of BAG3 at these aggregates hindered alternative pathways that might have been able to remove them. Further studies of FLNC-aggregates produced by a wide range of variants are needed in order to elucidate the mechanisms by which these aggregates persist, and to develop potential methods to clear them.
In summary, we identified two novel FLNC missense variants causing a distinct RCM phenotype in two families, and further demonstrated these variants lead to protein localization defects in vitro. This study provides new variants and additional evidence for the wide spectrum of currently known FLNC variants, and bolsters support for the inclusion of FLNC in genetic testing of CM patients.
ACKNOWLEDGMENTS
We thank members of both families who participated in this study. We thank Maria Padua for a critical reading of the manuscript.
ORCID
Stephanie M. Ware http://orcid.org/0000-0003-4714-0142
